FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
3,713 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | Injection, SolutionIntramuscular, Intravenous | ProPharma Distribution | ANDA | 84549-203 | 84549-0203-42 | — |
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | Injection, SolutionIntramuscular, Intravenous | ProPharma Distribution | ANDA | 84549-204 | 84549-0204-42 | — |
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | Injection, SolutionIntramuscular, Intravenous | ProPharma Distribution | ANDA | 84549-205 | 84549-0205-41 | — |
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | ProPharma Distribution |
| ANDA |
| 84549-543 |
| 84549-0543-25 |
| — |
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | Jvet Pharmaceuticals LLC | ANDA | 86211-113 | 86211-0113-10 | — |
|---|
| Glycopyrrolate 1Mlglycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | XIROMED LLC | ANDA | 70700-264 | 70700-0264-22 | — |
|---|
| Glycopyrrolate Oral Solution | Glycopyrrolate 1 mg/5mL | LiquidOral | Sun Pharmaceutical Industries, Inc. | ANDA | 51672-5316 | 51672-5316-09 | — |
|---|
| Glycopyrrolate Oral Solutionglycopyrrolate | Glycopyrrolate 1 mg/5mL | SolutionOral | Granules Pharmaceuticals Inc. | ANDA | 70010-106 | 70010-0106-44 | — |
|---|
| Glycopyrrolate Oral Solutionglycopyrrolate | Glycopyrrolate 1 mg/5mL | SolutionOral | AJENAT PHARMACEUTICALS LLC | ANDA | 82983-428 | 82983-0428-47 | — |
|---|
| GlyCylicsalicylic acid | Salicylic acid 17 g/100mL | LiquidTopical | The Tetra Corporation | OTC monograph drug | 49406-009 | 49406-0009-15 | — |
|---|
| Glycyrrhiza Glabra | Glycyrrhiza glabra 30 [hp_C]/30[hp_C] | PelletOral | Boiron | Unapproved homeopathic | 0220-2305 | 00220-2305-41 | — |
|---|
| Glycyrrhiza Glabra | Glycyrrhiza glabra 6 [hp_C]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-0763 | 37662-0763-0137662-0763-0237662-0763-03 | — |
|---|
| Glycyrrhiza Glabra | Glycyrrhiza glabra 12 [hp_C]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-0764 | 37662-0764-0137662-0764-0237662-0764-03 | — |
|---|
| Glycyrrhiza Glabra | Glycyrrhiza glabra 30 [hp_C]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-0765 | 37662-0765-0137662-0765-0237662-0765-03+1 more | — |
|---|
| Glycyrrhiza Glabra | Glycyrrhiza glabra 100 [hp_C]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-0766 | 37662-0766-0137662-0766-0237662-0766-03+1 more | — |
|---|
| Glycyrrhiza Glabra | Glycyrrhiza glabra 200 [hp_C]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-0767 | 37662-0767-0137662-0767-0237662-0767-03+1 more | — |
|---|
| Glycyrrhiza Glabra | Glycyrrhiza glabra 500 [hp_C]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-0768 | 37662-0768-0137662-0768-0237662-0768-03+1 more | — |
|---|
| Glycyrrhiza Glabra | Glycyrrhiza glabra 1 [hp_M]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-0769 | 37662-0769-0137662-0769-0237662-0769-03+1 more | — |
|---|
| glydolidocaine hydrochloride | Lidocaine hydrochloride anhydrous 20 mg/mL | JellyTopical | Sagent Pharmaceuticals | ANDA | 25021-673 | 25021-0673-7625021-0673-77 | — |
|---|
| GLYDO- lidocaine hydrochloride jelly | Lidocaine hydrochloride anhydrous 20 mg/mL | JellyTopical | HF Acquisition Co. LLC, DBA HealthFirst | ANDA | 51662-1652 | 51662-1652-01 | — |
|---|
| Glyoxal Combination 9303glyoxal combination | Gelsemium sempervirens root 3 [hp_X]/29.5mL + 7 more ingredients | LiquidOral | Professional Complementary Health Formulas | Unapproved homeopathic | 63083-9303 | 63083-9303-01 | — |
|---|
| Glyregaceticum acidum, cacao, magnesia sulphurica, natrum sulphuricum, verbascum thapsus, glandula suprarenalis suis, pancreas suis, cortisone aceticum, thyroidinum (suis), iodium, lycopodium clavatum, phosphorus, ranunculus bulbosus, saccharum officinale, vanadium metallicum, zincum metallicum, chromium acidum, culex musca | Acetic acid 3 [hp_X]/mL + 17 more ingredients | LiquidOral | Deseret Biologicals, Inc | Unapproved homeopathic | 43742-1931 | 43742-1931-01 | — |
|---|
| Glyrx-PFglycopyrrolate | Glycopyrrolate .2 mg/mL | Injection, SolutionIntramuscular, Intravenous | Exela Pharma Sciences, LLC | NDA | 51754-6000 | 51754-6000-04 | — |
|---|
| Glyrx-PFglycopyrrolate | Glycopyrrolate .2 mg/mL | Injection, SolutionIntramuscular, Intravenous | Exela Pharma Sciences, LLC | NDA | 51754-6001 | 51754-6001-04 | — |
|---|
| Glyrx-PFglycopyrrolate | Glycopyrrolate .2 mg/mL | Injection, SolutionIntramuscular, Intravenous | Exela Pharma Sciences, LLC | NDA | 51754-6013 | 51754-6013-03 | — |
|---|
| Glyrx-PFglycopyrrolate | Glycopyrrolate .2 mg/mL | Injection, SolutionIntramuscular, Intravenous | Exela Pharma Sciences, LLC | NDA | 51754-6015 | 51754-6015-03 | — |
|---|
| Glytone Acne BPO Treatment Gelbenzoyl peroxide gel | Benzoyl peroxide .05 g/g | GelTopical | Glytone, LLC | OTC monograph drug | 84262-030 | 84262-0030-01 | — |
|---|
| Glytone Daily Bodyglytone daily body lotion broad spectrum sunscreen spf 15 | Avobenzone 2 g/100g + 3 more ingredients | LotionTopical | Glytone, LLC | OTC monograph drug | 84262-027 | 84262-0027-01 | — |
|---|
| Glyxambiempagliflozin and linagliptin | Empagliflozin 25 mg/1; Linagliptin 5 mg/1 | Tablet, Film coatedOral | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | 0597-0164 | 00597-0164-3000597-0164-3900597-0164-90 | — |
|---|
| Glyxambiempagliflozin and linagliptin | Empagliflozin 10 mg/1; Linagliptin 5 mg/1 | Tablet, Film coatedOral | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | 0597-0182 | 00597-0182-3000597-0182-3900597-0182-90 | — |
|---|
| Gm Collin Puracnesalicylic acid | Salicylic acid 20 mg/mL | GelTopical | Laboratoires Dermo-Cosmetik Inc. | OTC monograph drug | 64127-195 | 64127-0195-01 | — |
|---|
| GM Collin SPF 25 UVA - UVB Urban Protection Veil Sunscreenzinc oxide and titanium dioxide | Zinc oxide 14.6 mg/100mL; Titanium dioxide 4.2 mg/100mL | CreamTopical | Laboratoires Dermo-Cosmetik Inc. | OTC monograph drug | 64127-234 | 64127-0234-01 | — |
|---|
| Gnaphalium | Pseudognaphalium obtusifolium 1 [hp_X]/mL | LiquidOral | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc | Unapproved homeopathic | 15631-2759 | 15631-2759-0015631-2759-01 | — |
|---|
| Gnaphalium polycephalumpseudognaphalium obtusifolium | Pseudognaphalium obtusifolium 30 [hp_C]/30[hp_C] | PelletOral | Boiron | Unapproved homeopathic | 0220-2306 | 00220-2306-41 | — |
|---|
| Gnaphalium polycephalumpseudognaphalium obtusifolium | Pseudognaphalium obtusifolium 200 [kp_C]/200[kp_C] | PelletOral | Boiron | Unapproved homeopathic | 0220-2307 | 00220-2307-41 | — |
|---|
| Gnaphalium polycephalumpseudognaphalium obtusifolium | Pseudognaphalium obtusifolium 9 [hp_C]/9[hp_C] | PelletOral | Boiron | Unapproved homeopathic | 0220-2310 | 00220-2310-41 | — |
|---|
| Gnaphalium polycephalumpseudognaphalium obtusifolium | Pseudognaphalium obtusifolium 6 [hp_C]/6[hp_C] | PelletOral | Boiron | Unapproved homeopathic | 0220-2313 | 00220-2313-41 | — |
|---|
| Gnaphalium Polycephalum | Pseudognaphalium obtusifolium 1 [hp_X]/1 | PelletOral | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc | Unapproved homeopathic | 15631-0208 | 15631-0208-0015631-0208-0115631-0208-02+5 more | — |
|---|
| Gnaphalium Polycephalum | Pseudognaphalium obtusifolium 6 [hp_C]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-0928 | 37662-0928-0137662-0928-0237662-0928-03 | — |
|---|
| Gnaphalium Polycephalum | Pseudognaphalium obtusifolium 12 [hp_C]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-0929 | 37662-0929-0137662-0929-0237662-0929-03 | — |
|---|
| Gnaphalium Polycephalum | Pseudognaphalium obtusifolium 30 [hp_C]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-0930 | 37662-0930-0137662-0930-0237662-0930-03+1 more | — |
|---|
| Gnaphalium Polycephalum | Pseudognaphalium obtusifolium 100 [hp_C]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-0931 | 37662-0931-0137662-0931-0237662-0931-03+1 more | — |
|---|
| Gnaphalium Polycephalum | Pseudognaphalium obtusifolium 200 [hp_C]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-0932 | 37662-0932-0137662-0932-0237662-0932-03+1 more | — |
|---|
| Gnaphalium Polycephalum | Pseudognaphalium obtusifolium 500 [hp_C]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-0933 | 37662-0933-0137662-0933-0237662-0933-03+1 more | — |
|---|
| Gnaphalium Polycephalum | Pseudognaphalium obtusifolium 1 [hp_M]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-0934 | 37662-0934-0137662-0934-0237662-0934-03+1 more | — |
|---|
| Gnaphalium Stannum | Bos taurus cerebellum 17 [hp_X]/mL + 7 more ingredients | LiquidOral | Uriel Pharmacy Inc. | Unapproved homeopathic | 48951-5027 | 48951-5027-01 | — |
|---|
| Gniby - LIDOCAINE ANORECTAL HEMORRHOIDALnumbing | Lidocaine 5 g/100g | CreamTopical | Putian Licheng District Zhijiancheng Trading Co., Ltd. | OTC monograph drug | 87152-002 | 87152-0002-0187152-0002-0287152-0002-03 | — |
|---|
| Gniby LIDOCAINE ANORECTAL HEMORRHOIDAL Numbinglidocaine | Lidocaine 5 g/100g | CreamTopical | Putian Licheng District Zhijiancheng Trading Co., Ltd. | OTC monograph drug | 87152-003 | 87152-0003-0187152-0003-0287152-0003-03 | — |
|---|
| GNP Anti Itchcamphor, menthol | Menthol .5 g/100g; Camphor (Synthetic) .5 g/100g | LotionTopical | AMERISOURCEBERGEN DRUG CORPORATION | OTC monograph drug | 46122-573 | 46122-0573-10 | — |
|---|
| GNP Calamine Topical Suspensioncalamine 8% and zinc oxide 8% | Zinc oxide 160 mg/mL | LotionTopical | Amerisource Bergen | OTC monograph drug | 24385-413 | 24385-0413-96 | — |
|---|